Covaxin 50% Effective When Delta Was Dominant, Shows Lancet Study

Two doses of Covaxin are 50 per cent effective against symptomatic disease, according to the first real-world assessment of India's indigenous COVID-19 vaccine published in The Lancet Infectious...